Skip to main content
OpenTrials
Completed

NCT Number: NCT00970112

Dexamethasone and Etoricoxib for Pain Prevention Following Periodontal Surgery

The purpose of this study is to investigate whether preemptive medication with dexamethasone or etoricoxib provides better pain management and control than placebo following periodontal surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

UEPG

Ponta Grossa, Paraná, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients presenting moderate or severe periodontitis after nonsurgical periodontal treatment with clinical signs of inflammation

Exclusion criteria

  • Pregnant
  • Diabetes mellitus
  • Heart diseases
  • Allergic to components of the medications
  • Risk of endocarditis

Treatment and study plan

Open Flap debridement

Procedure

Open flap debridement - access flap + scaling and root planning

Primary outcomes

  1. pain

    Time frame: up to 3 days

    hourly for the 8 first hours after surgery 3 times a day on the following 3 days

Sponsors and collaborators

Lead sponsor

Universidade Estadual de Ponta Grossa

Other

Registry information

Official study title

O Uso de Dexametasona e Etoricoxibe Para a prevenção e Controle da Dor pós-operatória após Cirurgia Periodontal

Important dates

Study start
2008
Primary completion
2009
Study completion
2010
First posted
Sep 2, 2009
Registry last updated
May 18, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.